Revision history of "Evaluation of Obestatin System/GPR39 as Therapeutic Target Potential in Gastric Cancer" (Q3141575)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 07:0407:04, 4 August 2022DG Regio talk contribs 70,371 bytes +47,838 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 12:1812:18, 2 December 2021DG Regio talk contribs 15,072 bytes +2,478 Created claim: summary (P836): Le système obestatin (Ob) et son récepteur GPR39 régulent l’expression de protéines distinctives de la transition de l’épithélium mésenchymique, de l’angiogenèse, de la morphologie cellulaire, de la prolifération et de l’invasion des cellules cancéreuses gastriques. Cet ensemble d’actions nous amène à postuler son applicabilité pour antagoniser les mécanismes fondamentaux associés au développement du cancer gastrique. Sa relation avec la pathoge...
  • curprev 12:1812:18, 2 December 2021DG Regio talk contribs 12,594 bytes +161 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 13:1613:16, 12 October 2021DG Regio talk contribs 12,433 bytes +145 Changed label, description and/or aliases in en: translated_label
  • curprev 13:1613:16, 12 October 2021DG Regio talk contribs 12,288 bytes +2,275 Created claim: summary (P836): The obestatin system (Ob) and its GPR39 receptor regulate the expression of distinctive proteins of the mesenchymal epithelium transition, angiogenesis, cell morphology, proliferation and invasion of gastric cancer cells. This set of actions leads us to postulate its applicability to antagonise the fundamental mechanisms associated with the development of gastric cancer. Its relationship with pathogenesis or clinical outcome of human gastric ade...

10 October 2021

9 October 2021

7 October 2021